VOGLIOS GM3

VOGLIOS GM3 is a powerful triple-combination anti-diabetic tablet containing Voglibose 0.3 mg, Metformin 500 mg, and Glimepiride 2 mg, formulated for the effective management of Type 2 Diabetes Mellitus. This advanced therapy targets fasting, post-prandial, and overall blood glucose levels for comprehensive glycemic control.
 

Key Benefits 

• Controls fasting and post-meal blood sugar levels
• Enhances insulin secretion and sensitivity
• Reduces glucose production in the liver
• Supports long-term diabetes management
• Suitable for patients requiring triple oral therapy